DOI:
10.1055/s-00000180
Journal of Neurological Surgery Part A: Central European Neurosurgery
LinksClose Window
References
van den Bent MJ, Brandes AA, Rampling R. , et al.
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.
J Clin Oncol 2009;
27 (08) 1268-1274
We do not assume any responsibility for the contents of the web pages of other providers.